How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

229 results for


Latest & greatest

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne Vulgaris

glycolic or other acids, masks, washes or soaps containing benzoyl peroxide (BPO), hydroquinone, sulfacetamide sodium or salicylic acid, non-mild facial cleansers, or moisturizers that contain retinol, salicylic acid, or α- or β-hydroxy acids . Using medications that are reported to exacerbate acne . Have had a facial procedure (chemical or laser peel, microdermabrasion, artificial ultraviolet therapy) performed by an esthetician, beautician, physician, nurse, or other practitioner, during the 4 weeks

2015 Clinical Trials

82. A Study Evaluating Blended Belotero for the Treatment of Etched-in Fine Facial Lines

in the study. They can continue using topicals with retinoids, retinol, beta hydroxy acids, or alpha hydroxyl acids if they were previously using these topicals for at least 3 months prior to starting the study, but they should not initiate cosmetic treatments with new topicals during the study period. They should not have cosmetic treatments such as chemical peels, microdermabrasion, microneedling procedures, laser procedures, botulinum toxin injections, or other injectable filler therapy in the treatment

2015 Clinical Trials

83. A Trial of Pulse Dyed Laser (Chromogenex Regenlite Transform) in the Treatment of Inflammatory Acne Vulgaris

brands/types of make-up for a minimum period of 14 days prior to study entry and must agree to use the same make-up brand/type and frequency of use throughout the study. Subjects must agree not to have any other procedures affecting skin quality (microdermabrasion, peels, acne treatments, etc.) for the duration of the study. Subjects must understand the study and be able to follow study instructions as well as attend the required study visits. Subjects who agree to be photographed for research

2015 Clinical Trials

84. SkinPen Efficacy on Acne Scars on the Face and/or Back

) to be treated. History of systemic granulomatous diseases. History of hypertrophic or keloid scars. Current cancerous or pre-cancerous lesions in area(s) to be treated. Had microdermabrasion or glycolic acid treatment to treatment area(s) within 1 month prior to study participation. History of chronic drug or alcohol abuse. Current smokers or have smoked in the last 5 years. History of cosmetic treatments: Skin tightening within last year, injectable filler of any type within the last year, neurotoxins

2015 Clinical Trials

85. Treatment of Melasma With Glycolic Acid-Salicylic Acid Peel Versus Glycolic Acid Peel

disease to facial area (i.e acne). Pregnant women, nursing mothers. Subjects with history of abnormal scaring Subjects who cannot communicate with investigators or who are unlikely to cooperate. Subjects in a situation in which in the opinion of the investigators, may interfere with optimal participation in the study. Subjects who have used chemical peels, microdermabrasion or facial laser treatments in the past 3 months. Contacts and Locations Go to No Contacts or Locations Provided More Information

2015 Clinical Trials

86. A Confirmatory Study for Evaluation of the Treatment by the Celluma3 of Periorbital Wrinkles

start, have: Had retinoid, microdermabrasion or prescription level glycolic acid treatments, or had any compromising procedure in the opinion of any clinical evaluator. Any other diagnosis of any contraindication in the current User Manual. Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its

2015 Clinical Trials

87. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser. (Abstract)

subjects with moderate to severe melasma were enrolled. Each subject had three laser treatments one month apart. Patients were followed up approximately 1 month, 3 months, and 6 months after the final laser treatment. A treatment session consisted of a microdermabrasion, 1064 nm QS laser, and topicals. Subjects were asked to rate treatment pain based on a numerical scale range 0-10 (0 = no pain and 10 = worst pain). A melasma area and severity index (MASI) grading system was applied. Also, melanin (...) in pigment reduction were noted between the two pulse durations. There was a statistically significant difference (P < 0.05) in pain scores reported by the subjects (scale 0-10), the mean pain score for 50 ns QS 1064 nm laser was 1.2 and for the 5 ns QS 2.9 the score was 2.9.In this study, we showed that a combination of microdermabrasion, QS1064 nm laser, and topicals decreased the MASI and meter scores without clinically significant side effects. Moreover, the longer pulsed Q switched 1064 nm laser i.e

2015 Lasers in surgery and medicine Controlled trial quality: uncertain

88. A Survey Comparing Delegation of Cosmetic Procedures Between Dermatologists and Nondermatologists. (Abstract)

and filler injections, laser hair removal, pulsed dye laser, tattoo removal, intense pulsed light, nonablative fractional laser, and sclerotherapy. No difference in delegation rate was noted between dermatologists and non-dermatologist physicians with respect to microdermabrasion, ablative fractional laser, cryolipolysis, radiofrequency skin tightening, focused ultrasound skin tightening, and focused ultrasound fat reduction.Dermatologists delegate procedures to NPP less frequently than non-dermatologist

2015 Dermatologic Surgery

89. A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions

participation. Had skin cancer treatment in preceding 12 months. Has damaged skin on facial areas (e.g., sunburn, tattoo, or scar). Had any medical procedure (e.g., laser resurfacing, chemical peel, or plastic surgery) on facial areas in preceding 12 months. Had any cosmetic procedure (e.g., microdermabrasion) on facial areas within 8 weeks of the baseline visit. Has any dermatological disorder that in the opinion of the Investigator may interfere with the accurate evaluation of the participant's facial (...) , or moisturizers that contain retinol, salicylic acid or α- or β-hydroxy acids. Uses medications known to exacerbate acne (e.g., mega-doses of vitamin D [>2000 IU/day] and vitamin B12 [>1 mg/day]; systemic steroids; androgens; haloperidol; halogens such as iodide and bromide; lithium; hydantoin; and phenobarbital). Has had any facial procedure (e.g., blue light, chemical or laser peel, microdermabrasion) performed by any practitioner within 4 weeks before the study started or during the course of the study

2014 Clinical Trials

90. Photodynamic Therapy for Papulopustular Rosacea

of systemic antibiotics within 1 month prior to Visit 1 Use of topical retinoids (on the face) within 1 month prior to Visit 1 Use of systemic retinoids, including isotretinoin, within 6 months prior to Visit 1. Use of laser or light based rosacea treatments (on the face) within 1 month prior to Visit 1 Cosmetic procedures (e.g., superficial chemical peels, exfoliation or microdermabrasion of the face) within 2 months prior to Visit 1 Use of topical corticosteroids (on the face) 1 month prior to Visit 1

2014 Clinical Trials

91. Combination Alexandrite Laser and Topical Therapy vs Topical Therapy Alone for Treatment of Melasma

of the date of study entry; Subject unwilling to refrain from any facial cosmetic procedures during the study period (e.g., chemical peels, resurfacing, microdermabrasion, etc.); Subject has initiated treatment with hormones including estrogen, progesterone and/or oral contraceptives within 3 months of study entry, or who intend to discontinue hormonal therapy during the study; Subject has participated in a clinical research study within the last 30 days prior to enrollment; Subject is unable

2014 Clinical Trials

92. Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris

-associated colitis) or similar symptoms. Prior Therapy: Have received treatment with the following therapies at the times specified prior to Baseline: systemic retinoids [6 months]; systemic antibiotics, investigational therapy, facial procedure (chemical or laser peel, microdermabrasion, artificial UV therapy), topical corticosteroids on the face or systemic corticosteroids [4 weeks]; topical antibiotics on the face, topical anti-acne medications (eg, BPO, retinoids, azelaic acid, resorcinol

2014 Clinical Trials

93. Pharmacokinetic Study of MTC896 Gel in Subjects With Acne

A supplements greater than 10,000 units/day within 6 months of Baseline; Facial procedures (chemical or laser peel, microdermabrasion, etc.) within the past 8 weeks or during the study. Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its identifier (NCT number): NCT02293018 Locations

2014 Clinical Trials

94. Oral Isotretinoin Versus Topical Tretinoin for Actinic Keratosis

3% in hyauronic acid gel, photodynamic therapy, 5-FU, in the last 6 months; Absence of previous treatment in the face and forearms with chemical peels and microdermabrasion, in the last 6 months; Absence of previous treatment with oral retinoids in the last 6 months; Absence of anti-cancer chemotherapy in the last 3 months; Absence of hypersensitivity to parabens (present in the majority of drugs as a preserving agent); Absence of infectious or inflammatory diseases in the face and forearms (...) months; Previous treatment in the face and forearms with chemical peels and microdermabrasion, in the last 6 months; 8. Previous treatment with oral retinoids in the last 6 months For the isotretinoin group (ISO): Presence of significative hepatic laboratory alterations (elevated liver enzymes twice ashigh as the upper normal limit; Diabetic patients, with fast glucose values superior to 110mg/dl; Significant lipid profile alterations (triglycerides > 300 mg/dl; total cholesterol> 250 mg/dl); Low

2014 Clinical Trials

95. Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + ALA Photodynamic Therapy

Retinoids, including tazarotene, adapalene, tretinoin, within 4 weeks Microdermabrasion, laser ablative treatments, ALA-PDT, chemical peels, 5-fluorouracil (5-FU), diclofenac, ingenol mebutate, imiquimod or other topical treatments for AK within 8 weeks use of systemic retinoid therapy within 6 months Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided

2014 Clinical Trials

96. Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Pump, Cetaphil® DermaControl™ Moisturizer SPF 30, and Cetaphil® DermaControl™ Foam Wash Regimen in Student Athletes With Mild to Moderate Acne Vulgaris

) on the face (excluding the nose). Agree to use the provided study products as their only acne treatment, facial wash and facial moisturizer for the duration of the study. Agree to refrain from temporary and permanent tattoos, paint, or other facial art (including, but not limited to piercings), cosmetic procedures and devices (including, but not limited to facial peels, microdermabrasion and Clarisonic®) on the face for the duration of the study. Subjects aged 12-17 must be willing to read and provide (...) of the study. Subjects with a history of procedures such as microdermabrasion, chemical peels, intense pulsed light, fillers, Botox®, lasers, photodynamic therapy, red and blue light therapy, etc. in the last 90 days. Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its identifier (NCT

2014 Clinical Trials

97. The Efficacy and Safety of 3% Povidone-Iodine in Acne Therapy

a facial procedure - chemical or laser peel or microdermabrasion 2 weeks before the study No topical antiacne products 2 weeks prior to study commencement till its conclusion. No systemic corticosteroids 4 weeks prior to study start No systemic retinoids 3 months prior to study start No concurrent use of tanning booths or sunbathing Any condition in the judgement of the investigator that may place the person at unacceptable risk for participation Any subject who participated in another clinical trial

2014 Clinical Trials

98. A Study of the RevLite Laser System for the Treatment of Refractory Mixed Type Melasma

the need to be exposed to artificial tanning devices or excessive sunlight during the trial. The subject has had prior treatment with parenteral gold therapy (gold sodium thiomalate). The subject has Diabetes Type 1 or 2. The subject has a sensitivity to hydroquinone or Retin-A. The subject has evidence of a compromised immune system or hepatitis. Has had microdermabrasion in past 3 months, other laser or Intense Pulsed Light treatment or chemical peels to the face in past 6 months, injectable fillers

2014 Clinical Trials

99. Pivotal Study of Sebacia Microparticles in the Treatment of Acne Vulgaris

acne Active concomitant skin disease, excessive scarring or excess facial hair Heavily tanned skin; unable or unwilling to avoid tanning beds/excessive sun exposure Acne medication and therapy restrictions - time period prior to Baseline (below) Oral retinoids - 6 months Other systemic medications - 4 weeks Topical retinoids, steroids, antibiotics - 2 weeks OTC topical treatments - 1 week Light treatments (including IPL or laser), microdermabrasion and/or peels - 8 weeks Investigational drug

2014 Clinical Trials

100. BOTOX® in the Treatment of Crow's Feet Lines in China

sclerosis Facial laser or light treatment, microdermabrasion or chemical peels within 3 months Radio frequency laser treatments, phototherapy, blepharoplasty, brow-lift or related procedure, permanent make-up, oral retinoid therapy or treatment with non-permanent soft tissue fillers within 1 year Any medium-depth or deep facial peels within 5 years Periorbital surgery, face-lift, mid facial or periorbital treatment with permanent soft tissue fillers, synthetic implants or autologous fat transplant

2014 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>